Evidence map›Paper›PMID 39131324›Full record

ArticlebioRxiv : the preprint server for biology2024

Introducing 'identification probability' for automated and transferable assessment of metabolite identification confidence in metabolomics and related studies.

Thomas O Metz, Christine H Chang, Vasuk Gautam, Afia Anjum, Siyang Tian, Fei Wang, Sean M Colby, Jamie R Nunez, Madison R Blumer, Arthur S Edison and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Thomas O MetzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA USA.ORCID 0000-0001-6049-3968
Christine H ChangBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA USA.
Vasuk GautamDepartment of Biological Sciences, University of Alberta, Edmonton, AB, Canada.
Afia AnjumDepartment of Biological Sciences, University of Alberta, Edmonton, AB, Canada.
Siyang TianDepartment of Biological Sciences, University of Alberta, Edmonton, AB, Canada.
Fei WangDepartment of Computing Science, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0002-0191-9719
Sean M ColbyBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA USA.
Jamie R NunezBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA USA.
Madison R BlumerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA USA.
Arthur S EdisonDepartment of Biochemistry & Molecular Biology, Complex Carbohydrate Research Center and Institute of Bioinformatics, University of Georgia, Athens, GA, USA.ORCID 0000-0002-5686-2350
Oliver FiehnWest Coast Metabolomics Center, University of California Davis, Davis, CA, USA.ORCID 0000-0002-6261-8928
Dean P JonesClinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-2090-0677
Shuzhao LiThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.ORCID 0000-0002-7386-2539
Edward T MorganDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0003-4273-2261
Gary J PattiCenter for Mass Spectrometry and Metabolic Tracing, Department of Chemistry, Department of Medicine, Washington University, Saint Louis, Missouri, USA.ORCID 0000-0002-3748-6193
Dylan H RossBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA USA.ORCID 0009-0005-2943-2282
Madelyn R ShapiroArtificial Intelligence & Data Analytics Division, Pacific Northwest National Laboratory, Richland, WA USA.
Antony J WilliamsU.S. Environmental Protection Agency, Office of Research & Development, Center for Computational Toxicology & Exposure (CCTE), Research Triangle Park, NC USA.ORCID 0000-0002-2668-4821
David S WishartDepartment of Biological Sciences, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0002-3207-2434

Funding

Developing Metabolomic Technologies to Advance Environmental Exposure AnalysisR35ES028365 · NIEHS · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2017 to 2024
$5.9M
Pacific Northwest Advanced Compound Identification CoreU2CES030170 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI METZ, THOMAS O · 2018 to 2021
$4.6M
Portal for Open Computational Metabolomics Tools - Yr 4 U2C SupplementU2CES030167 · NIEHS · UNIVERSITY OF GEORGIA · PI MCINTYRE, LAUREN M. · 2018 to 2021
$4.2M
West Coast Metabolomics Center for Compound IdentificationU2CES030158 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2018 to 2021
$4.1M
U2C Experimental CoreU2CES030163 · NIEHS · EMORY UNIVERSITY · PI MORGAN, EDWARD THOMAS · 2018 to 2021
$3.6M
A Comprehensive Platform for High-Throughput Profiling of the Human Reference MetabolomeU01CA235482 · NCI · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2018 to 2021
$1.8M
A reproducible database for untargeted metabolomics data processing across laboratoriesR01GM155383 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHARLES ROBERT EVANS, Oliver Fiehn · 2024 to 2026
$1.5M
NCI NIH HHS U01 CA235482NIEHS NIH HHS R35 ES028365NIEHS NIH HHS U2C ES030158NIEHS NIH HHS U2C ES030163NIEHS NIH HHS U2C ES030167NIEHS NIH HHS U2C ES030170NIGMS NIH HHS R01 GM155383
6 · The paper itself

Abstract

Methods for assessing compound identification confidence in metabolomics and related studies have been debated and actively researched for the past two decades. The earliest effort in 2007 focused primarily on mass spectrometry and nuclear magnetic resonance spectroscopy and resulted in four recommended levels of metabolite identification confidence - the Metabolite Standards Initiative (MSI) Levels. In 2014, the original MSI Levels were expanded to five levels (including two sublevels) to facilitate communication of compound identification confidence in high resolution mass spectrometry studies. Further refinement in identification levels have occurred, for example to accommodate use of ion mobility spectrometry in metabolomics workflows, and alternate approaches to communicate compound identification confidence also have been developed based on identification points schema. However, neither qualitative levels of identification confidence nor quantitative scoring systems address the degree of ambiguity in compound identifications in context of the chemical space being considered, are easily automated, or are transferable between analytical platforms. In this perspective, we propose that the metabolomics and related communities consider identification probability as an approach for automated and transferable assessment of compound identification and ambiguity in metabolomics and related studies. Identification probability is defined simply as 1/N, where N is the number of compounds in a reference library or chemical space that match to an experimentally measured molecule within user-defined measurement precision(s), for example mass measurement or retention time accuracy, etc. We demonstrate the utility of identification probability in an

Identifiers

PMID39131324
PMCPMC11312557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.